Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹1,475.00
Market cap: ₹2,107 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 48.1×Sector 47.4×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 2 Acquisition 2 Results Update 1 Product Launch 1 Other Announcement 1 Financial Results 1 Earnings Call 1 Business Update 1 Bonus Issue 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Sep 2026 18:28 IST BSE

Capital Structure Change

Fredun Pharmaceuticals Capital Structure Change

Fredun Pharmaceuticals allotted 3,61,599 equity shares following the conversion of 1,20,533 warrants. This allotment was executed at an issue price of Rs. 1,250 per warrant.

Value: ₹15.07 Cr

Read the filing ↗

17 Jul 2026 13:05 IST BSE

Capital Structure Change

Fredun Pharmaceuticals Capital Structure Change

Fredun Pharmaceuticals allotted 1.10 crore bonus shares in a 2:1 ratio. Post-issue paid-up capital increased to Rs 16.54 crore from Rs 5.51 crore.

Read the filing ↗